Skip to main content
Article thumbnail
Location of Repository

PET/MRI in infectious and inflammatory diseases: will it be a useful improvement?

By Andor W. J. M. Glaudemans, Ana Maria Quintero and Alberto Signore
Topics: Editorial
Publisher: Springer-Verlag
OAI identifier: oai:pubmedcentral.nih.gov:3326233
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. An autoradiographic study of [(18)F]FDG uptake to islets of Langerhans
    2. (2012). Can sequential 18F-FDG PET/CT replace WBC imaging in the diabetic foot?
    3. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences.
    4. Fate of 2-deoxy-2-[18F]fluoro-D-glucose in control and diabetic rats.
    5. Free-breathing diffusion-weighted imaging for the assessment of inflammatory activity in Crohn’s disease.
    6. Guidelines for the labelling of leucocytes with (111)In-oxine.
    7. Guidelines for the labelling of leucocytes with (99m)Tc-HMPAO.
    8. Health technology assessment of magnetic resonance imaging of the spine and bone marrow.
    9. Imaging of cell trafficking in Crohn’s disease.
    10. (1999). In vivo imaging of insulitis in autoimmune diabetes.
    11. (1990). In vivo labelling of activated T lymphocytes by i.v. injection of 123I-IL2 for detection of insulitis in type 1 diabetes. Prog Clin Biol Res.
    12. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’sd i s e a s e .G u t .
    13. Magnetic resonance spectroscopy in clinical oncology.
    14. Molecular imaging perspectives.
    15. MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent.
    16. (1994). New approach for in vivo detection of insulitis in type I diabetes: activated lymphocyte targeting with 123Ilabelled interleukin 2. Eur J Endocrinol.
    17. Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients.
    18. Nuclear medicine imaging of diabetic foot infection: results of meta-analysis.
    19. (2001). Pancreatic fate ofa (125)I-labelled mouse monoclonal antibodydirected against pancreatic B-cell surface ganglioside(s) in control and diabetic rats. Cell Biochem Funct.
    20. Pancreatic glucose uptake in vivo in men with newly diagnosed type 1 diabetes.
    21. Pancreatic imaging: current and emerging technologies.
    22. (2008). Pancreatic scintigraphy with 99mTc-interleukin-2 at diagnosis of type 1 diabetes and after 1 year of nicotinamide therapy. Diabetes Metab Res Rev.
    23. (1998). Prognostic relevance of pancreatic uptake of technetium99m labelled human polyclonal immunoglobulins in patients with type 1 diabetes.
    24. Spondylodiscitis in the elderly patient: clinical mid-term results and quality of life. Arch Orthop Trauma Surg.
    25. Spondylodiscitis: update on diagnosis and management.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.